Antibody drugs for Alzheimer’s show glimmers of promise

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nature

• Publication date

  2015-07-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nature.2015.18031PMID 26223602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exercise in Alzheimer disease: comment on "Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial".

  2013cited by this paper
• Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

  2012cited by this paper
• Intermittent androgen suppression for rising PSA level after radiotherapy.

  2012cited by this paper

• Determination of bifurcation parameters and complex dynamics in Alzheimer's disease model

  2024cites this paper
• The Potency of Biomarkers for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease

  2022cites this paper
• Altered brain network centrality in patients with mild cognitive impairment: an fMRI study using a voxel-wise degree centrality approach

  2021cites this paper
• Editorial for “Individualized Prediction of Early Alzheimer's Disease Based on MRI Radiomics, Clinical and Laboratory Examinations: A 60‐Month Follow‐up Study”

  2021cites this paper
• Alzheimer’s Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease

  2020cites this paper
• The search for, and chemistry and mechanism of, neurotrophic natural products

  2020cites this paper
• Evaluation of Peripheral Immune Dysregulation in Alzheimer’s Disease and Vascular Dementia

  2019cites this paper
• Discovery of an Orally Bioavailable Benzofuran Analogue That Serves as a β-Amyloid Aggregation Inhibitor for the Potential Treatment of Alzheimer's Disease.

  2018cites this paper
• Visualization of Focal Thinning of the Ganglion Cell–Inner Plexiform Layer in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

  2018cites this paper
• Alzheimer's disease (AD) therapeutics – 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality

  2018cites this paper
• A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicity

  2018cites this paper
• 41 – Noninfectious Disease Vaccines

  2018cites this paper
• Chemical protein synthesis to study structure and function of amyloid fibers

  2018influential citation
• VERY‐LARGE‐SCALE PRODUCTION OF MONOCLONAL ANTIBODIES IN PLANTS

  2017cites this paper
• Emerging amyloid and tau targeting treatments for Alzheimer’s disease

  2017cites this paper
• The Role of ESX-1 in Mycobacterium tuberculosis Pathogenesis

  2017cites this paper
• Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer’s Disease

  2017cites this paper
• On expert curation and scalability: UniProtKB/Swiss-Prot as a case study

  2017cites this paper
• Indapamide suppresses amyloid-β production in cellular models of Alzheimer’s disease through regulating BACE1 activity

  2017cites this paper
• The Amyloid-beta Peptide in Amyloid Formation Processes : Interactions with Blood Proteins and Naturally Occurring Metal Ions

  2017cites this paper
• Retinal thickness in Alzheimer's disease: A systematic review and meta-analysis

  2017cites this paper
• [A bioactive implantable device to prevent Alzheimer's disease].

  2017cites this paper
• Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia

  2017cites this paper
• Cerebral blood flow abnormality in clinically diagnosed Alzheimer's disease patients with or without amyloid β accumulation on positron emission tomography

  2017cites this paper
• Biomarkers in Neurodegenerative Diseases.

  2017cites this paper
• Alzheimer's Disease-like Early-phase Brain Pathogenesis: Self-curing Amelioration of Neurodegeneration from Pro-inflammatory 'Wounding' to Anti-inflammatory 'Healing'.

  2017cites this paper
• Genetic ablation of the p66Shc adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer’s disease

  2017cites this paper
• The midbrain‐to‐pons ratio distinguishes progressive supranuclear palsy from non‐fluent primary progressive aphasias

  2017cites this paper
• Antibody therapies in CNS diseases

  2017cites this paper
• Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies.

  2017cites this paper
• Revealing different aggregational states of a conjugated polymer in solution by a nanopore sensor† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c6sc00296j

  2016cites this paper
• Mathematical model on Alzheimer’s disease

  2016cites this paper
• Biotic/Abiotic Stress-Driven Alzheimer's Disease

  2016cites this paper
• Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment

  2016cites this paper
• Young microglia restore amyloid plaque clearance of aged microglia

  2016cites this paper
• Targeting microglia for the treatment of Alzheimer's Disease

  2016cites this paper
• Towards Personalized Intervention for Alzheimer’s Disease

  2016cites this paper
• Biomarkers for the Early Detection and Progression of Alzheimer’s Disease

  2016cites this paper
• Chiral recognition in amyloid fiber growth

  2016cites this paper
• Integrating Estimates of the Social and Individual Costs of Caregiving into Dementia Treatment Trials

  2016cites this paper
• Expanding the phenotypic associations of globular glial tau subtypes

  2016cites this paper
• Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis*

  2016cites this paper
• Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies

  2016cites this paper
• Goldilocks' Determination of What New In Vivo Data are "Just Right" for Different Common Drug Development Scenarios, Part 1.

  2016cites this paper
• Medicinal Chemistry Focusing on Aggregation of Amyloid-β.

  2016cites this paper
• Cognitive Reserve in Alzheimer’s Dementia: Diagnostic Accuracy of a Testing-the-Limits Paradigm

  2016cites this paper
• Differential Toxicity of Antibodies to the Prion Protein

  2016cites this paper
• Aβ immunotherapy for Alzheimer's disease: where are we?

  2016cites this paper
• Perturbation of the transcriptome: implications of the innate immune system in Alzheimer's disease.

  2016cites this paper
• Self-Assembled Cyclic d,l-α-Peptides as Generic Conformational Inhibitors of the α-Synuclein Aggregation and Toxicity: In Vitro and Mechanistic Studies.

  2016cites this paper
• On expert curation and sustainability: UniProtKB/Swiss-Prot as a case study

  2016cites this paper
• Antibody Approaches To Treat Brain Diseases

  2016cites this paper
• A Novel Multifunctional Compound Camellikaempferoside B Decreases Aβ Production, Interferes with Aβ Aggregation, and Prohibits Aβ-Mediated Neurotoxicity and Neuroinflammation.

  2016cites this paper
• Anti-Aβ Antibodies in the Fighting with Alzheimer’s Disease

  2016cites this paper
• Can Alzheimer's Patients Receive and Store Information in Late Stage of the Disease and Can Memory be Restored if the Amyloid Plaques are Removed?

  2015cites this paper
• A New Use for an Old Treatment: Radiation Therapy and Alzheimer's Disease

  2012cites this paper
• Acta Universitatis Upsaliensis Uppsala 2015

  year unknowncites this paper